Leukocyte activation: Relation to cardiovascular mortality after cerebrovascular ischemia

Cerebrovascular Diseases

Volumn 10, Issue 2, 2000, Pages 97-101

  Falke, P ^a   Elneihoum, A M ^a   Ohlsson, K ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Cerebral ischemia; Cytokines; Leukocyte; Mortality

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; GELATINASE; LIPOCALIN; PROTEINASE; SYNAPSIN I; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; OBSERVATION; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; STROKE; TRANSIENT ISCHEMIC ATTACK;

ACUTE-PHASE PROTEINS; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASES; CARRIER PROTEINS; CEREBROVASCULAR ACCIDENT; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; MYELOBLASTIN; NEUTROPHIL ACTIVATION; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RISK FACTORS; SERINE ENDOPEPTIDASES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0033974568     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000016037     Document Type: Article

References (31)

1. Friedman GD, Klatsky AL, Siegelaub AB: The leukocyte count as a predictor of myocardial infarction. N Engl J Med 1974;290:1275-1278.
2. Prentice RL, Szatrowski TP, Kato H, Mason MW: Leukocyte counts and cerebrovascular disease. J Chronic Dis 1982;35:703-714.
3. Shlant RC, Forman S, Stamler V, Canner PL: The natural history of coronary heart disease: Prognostic factors after recovery from myocardial infarction in 2,789 men. Circulation 1982; 66:401-408.
4. Lowe GD, Machado SG, Krol WF, Barton BA, Forbes CD: White blood cell count and hematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemost 1985; 54:700-703.
5. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA Jr: Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin-1. Proc Natl Acad Sci USA 1986;83:4533-4537.
6. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA Jr: Interleukin-1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984;160:618-623.
7. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994;76:301-314.
8. Del Maschio A, Evangelista V, Rajtar G, Chen ZM, Cerletti C, De Gaetano G: Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents. Am J Physiol 1990; 258(3 pt2):H870-H879.
9. Nash GB: Adhesion between neutrophil and platelets: A modulator of thrombotic and inflammatory events. Thromb Res 1994;74:S3-S11.
10. Østerud B: A global view of the role of monocytes and platelets in atherogenesis. Thromb Res 1997;85:1-22.
11. van Deventer SJH, Büller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A: Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 1990;76:2520-2526.
12. van der Wal A, Becker AE, van der Loos CM, Das PK: Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammation process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
13. Mehta JL, Nichols WW, Mehta P: Neutrophils as potential participants in acute myocardial ischemia: Relevance to reperfusion. J Am Coll Cardiol 1988;11:1309-1316.
14. del Zoppo GJ, Schmid-Schönbein GW, Mori E, Copeland BR, Chang CM: Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 1991;22:1276-1283.
15. Axelsson L, Bergenfeldt M, Ohlsson K: Studies of the release and turnover of a human lipocalin. Scand J Clin Lab Invest 1995;55:577-588.
16. Kjeldsen L, Johnsen AH, Sengeløv H, Borregaard N: Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993;268: 10425-10432.
17. Lundberg E, Bergenfeldt M, Ohlsson K: Release of immunoreactive human neutrophil proteinase 4, normally and in peritonitis. Scand J Clin Lab Invest 1991;51:23-29.
18. Aggarwal BB, Kohr WJ, Hass PE, Moffat B, Spencer SA, Henzel WJ, Bringman TS, Nedwin GE, Goeddel DV, Harkins RN: Human tumor necrosis factor. Production, purification and characterization. J Biol Chem 1985;260: 2345-2354.
19. Peetre C, Thysell H, Grubb A, Olsson I: A tumor necrosis factor binding protein is present in human biological fluids. Eur J Haematol 1988;41:414-419.
20. Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D: Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995;54:1-8.
21. Engelberts I, Moller A, Schoen GI, van-der-Linden CJ, Buurman WA: Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Cytokine Res 1991;10:69-76.
22. Elneihoum AM, Falke P, Axelsson L, Lundberg E, Lindgärde F, Ohlsson K: Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke 1996;27: 1734-1738.
23. Anwaar I, Gottsäter A, Ohlsson K, Lindgärde F, Mattaisson I: Increasing levels of leukocyte derived inflammatory mediators in plasma and cAMP in platelets during follow-up after acute cerebral ischemia. Cerebrovasc Dis 1998;8: 310-317.
24. Beamer NB, Coull BM, Clork WM, Briley DP, Wynn DO, Sexton G: Persistent inflammatory response in stroke survivors. Neurology 1998; 50:1722-1728.
25. Bonita R: Epidemiology of stroke. Lancet 1992;339:342-347.
26. Ohlsson K, Linder C, Lundberg E, Axelsson L: Release of cytokines and proteases from human peripheral blood mononuclear and polymorphonuclear cells following phagocytosis and LPS stimulation. Scand J Clin Lab Invest 1996;56:461-470.
27. Falke P, Jerntop P, Pessah-Rasmussen H: Differences in cardiac disease prevalence and in blood variables between major and minor stroke patients. Int Angiol 1993;12:5-8.
28. Burr ML, Holliday RM, Fehily AM, Whitehead PJ: Haematological prognostic indices after myocardial infarction: Evidence from the Diet and Reinfarction. Trial (DART). Eur Heart J 1992;13:166-170.
29. Liuzzo G, Biascucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A: Prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-424.
30. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and risk for cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979.
31. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97: 425-428.